N-tert-Butyloxycarbonyl Silodosin N-oxide
Rif. TR-B465095
10mg | Fuori produzione | ||
25mg | Fuori produzione | ||
50mg | Fuori produzione |
Informazioni sul prodotto
- 5-((R)-2-((tert-Butoxycarbonyl)(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)-7-carbamoyl-1-(3-hydroxypropyl)indoline 1-Oxide
Applications N-tert-Butyloxycarbonyl Silodosin N-oxide is an intermediate in the synthesis of Silodosin N-Oxide (S465045) which is an N-oxide metabolite or degradation product of the drug Silodosin (S465000) which is an α1a-adrenoceptor antagonist. It is used in treatment of benign prostatic hypertophy.
References Shibata, K., et al.: Mol. Pharmacol., 48, 250 (1995), Murata, S., et al.: J. Urol., 164, 578 (2000),